Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-29 · accession 0001822629-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | 2024-02-29 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $67.67 | -10.0K | 473.9K | -2% | -$677.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-29 | F | D | 10,014 | $67.67 | 473,946 | D | — | — |